Biotage AB – changes in number of shares and votes
As previously announced, the shareholders resolved at the Annual General Meeting held on 28 April 2014 to withdraw 5,146,883 shares, which had been repurchased under the company’s re-purchase program. Following withdrawal of these shares the number of outstanding shares and votes amounts to 64,714,447 as of 30 April 2014.
Torben Jörgensen, President and CEO
Phone: +46 707-49 05 84, firstname.lastname@example.org
Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 2pm on 30 April 2014.
Biotage offers efficient separation technologies for use within analytical all the way up to industrial scale as well as highly qualitative solutions for analytical chemistry in research and at commercial analytical laboratories. Biotage’s products are used by e.g. governmental authorities, academic institutions, pharma and food industries. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 445 MSEK in 2013. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com